NICE to review anti-TNF decision in RA

NICE has announced that it will review its decision to restrict the use of anti-TNF drugs for patients with rheumatoid arthritis (RA).

Credit: JH Lancy
Credit: JH Lancy

The U-turn comes after NICE announced last year that people with severe RA would not be permitted to try a second anti-TNF drug.

The decision resulted in an appeal by the Arthritis and Musculoskeletal Alliance (ARMA), the umbrella group for the charity Arthritis Care.

Rachel Haynes, director of public affairs at Arthritis Care, said: ‘We hope that NICE will put the needs of people above costs and reach the right conclusion quickly.

‘Not prescribing these life-transforming drugs to their full potential is like inventing the wheel but not using it because it is cheaper to walk.’

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...

Vaccines

Monkeypox jabs will run out by next week, UKHSA says

The UK is likely to run out of smallpox vaccine stocks which it is using to protect...

NHS sign outside a building

Two Midlands hospitals end partnerships with Babylon

Two NHS trusts have prematurely severed their relationships with digital health provider,...